Bellevue Group AG - 18 Aug 2025 SCHEDULE 13G Report for Celldex Therapeutics, Inc. Common Stock (CLDX)

Filing Manager
Bellevue Group AG
Reporting Manager
Bellevue Group AG
Security
Celldex Therapeutics, Inc. Common Stock
Symbol
CLDX
Shares outstanding
66,993,870 shares
Disclosed Ownership
3,617,669 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 19:58:46 UTC
Date of event
18 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bellevue Group AG 5.4% 3,617,669 0 3,617,669 /s/ Stefano Montalbano Stefano Montalbano/ Chief Financial Officer
Bellevue Asset Management AG 5.4% 3,617,669 0 3,617,669 /s/ Christoph Eisenring Christoph Eisenring/ Head Legal & Compliance